Meridien Research- Tampa

Tampa, Florida 33606

We've found

1 trials

at this facility

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Tampa, FL

Use our guide to learn which trials are right for you!